Skip to Content

Remifentanil Injection

Last Updated: February 10, 2018
Status: Current

Remifentanil Injection

Products Affected - Description
  • Ultiva lyophilized powder for injection, Mylan Institutional
    1 mg, vial, 10 count (NDC 67457-0198-03)
    2 mg, vial, 10 count (NDC 67457-0198-05)
    5 mg, vial, 10 count (NDC 67457-0198-10)

Reason for the Shortage
    • Mylan Institutional did not provide a reason for the shortage.
    • Fresnius Kabi launched generic remifentanil in January 2018.
Available Products
  • Remifentanil lyophilized powder for injection, Fresenius Kabi
    1 mg, vial, 10 count (NDC 63323-0723-03)
    2 mg, vial, 10 count (NDC 63323-0724-05)
    5 mg, vial, 10 count (NDC 63323-0725-10)

Estimated Resupply Dates

  • Mylan Institutional has Ultiva 1 mg, 2 mg, and 5 mg vials on back order and the company estimates a release date of late-March 2018 for the 1 mg vials, late-April 2018 for the 2 mg vials, and mid-April 2018 for the 5 mg vials.

Updated

February 10, January 19 and 2, 2018, University of Utah, Drug Information Service. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide